OPRX · ISSUER CIK 1448431
OptimizeRx Corp
Between Aug 1, 2026 and Oct 29, 2026, 5 OptimizeRx Corp insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Oct 2, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 202610:00 | Oct 1, 2026 | OPRX | Chief Business Officer | F · Tax | $8.39 | −414 | 99,246 | -0% | $3K | ||
| Sep 2, 202615:20 | Sep 1, 2026 | OPRX | Chief Business Officer | F · Tax | $7.86 | −1,432 | 99,660 | -1% | $11K | ||
| Aug 24, 202616:58 | Aug 20, 2026 | OPRX | Chief Executive Officer | A · Grant | — | +79,200 | 262,751 | +43% | — | ||
| Aug 24, 202616:58 | Aug 20, 2026 | OPRX | Chief Business Officer | A · Grant | — | +57,600 | 101,092 | +132% | — | ||
| Aug 24, 202616:57 | Aug 20, 2026 | OPRX | CHIEF OPERATING OFFICER | A · Grant | — | +57,600 | 82,787 | +229% | — | ||
| Aug 24, 202616:57 | Aug 20, 2026 | OPRX | Chief Legal & Admin Officer | A · Grant | — | +57,600 | 148,007 | +64% | — | ||
| Aug 24, 202615:14 | Aug 21, 2026 | OPRX | CHIEF OPERATING OFFICER | F · Tax | $7.71 | −1,020 | 25,187 | -4% | $8K | ||
| Aug 24, 202615:14 | Aug 21, 2026 | OPRX | Chief Executive Officer | F · Tax | $7.71 | −1,737 | 183,551 | -1% | $13K | ||
| Aug 24, 202615:12 | Aug 21, 2026 | OPRX | Chief Legal & Admin Officer | F · Tax | $7.71 | −1,529 | 90,407 | -2% | $12K | ||
| Aug 24, 202615:12 | Aug 21, 2026 | OPRX | Chief Business Officer | F · Tax | $7.71 | −1,243 | 43,492 | -3% | $10K | ||
| Aug 24, 202615:11 | Aug 21, 2026 | OPRX | Chief Finance & Strat Officer | F · Tax | $7.71 | −1,381 | 121,791 | -1% | $11K |